Alicja Januszewicz
Direttore/Membro del Consiglio presso Women In The Enterprise of Science & Technology
Posizioni attive di Alicja Januszewicz
Società | Posizione | Inizio | Fine |
---|---|---|---|
Women In The Enterprise of Science & Technology
Women In The Enterprise of Science & Technology Miscellaneous Commercial ServicesCommercial Services Women In The Enterprise of Science & Technology operates as a forum for women in enterprise of science and technology, providing inspiration, knowledge, and connections. The non-profit company is based in Cambridge. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Alicja Januszewicz
Precedenti posizioni note di Alicja Januszewicz
Società | Posizione | Inizio | Fine |
---|---|---|---|
THESEUS PHARMACEUTICALS, INC. | Ufficiale delle Risorse Umane | 16/12/2021 | 01/11/2022 |
BAXTER INTERNATIONAL INC. | Ufficiale delle Risorse Umane | 01/08/2015 | 01/11/2016 |
EPIZYME, INC. | Corporate Officer/Principal | 01/01/2007 | 01/01/2013 |
ALLENA PHARMACEUTICALS, INC. | Ufficiale delle Risorse Umane | 01/01/2019 | - |
Formazione di Alicja Januszewicz
Polish Academy of Sciences | Doctorate Degree |
Kenan-Flagler Business School | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Polonia | 2 |
Posizioni
Human Resources Officer | 3 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Settori
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
BAXTER INTERNATIONAL INC. | Health Technology |
ALLENA PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 3 |
---|---|
Epizyme, Inc.
Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
Women In The Enterprise of Science & Technology
Women In The Enterprise of Science & Technology Miscellaneous Commercial ServicesCommercial Services Women In The Enterprise of Science & Technology operates as a forum for women in enterprise of science and technology, providing inspiration, knowledge, and connections. The non-profit company is based in Cambridge. | Commercial Services |
Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Alicja Januszewicz
- Esperienza